Day-6 bone marrow aspirate for the predi
β
Peters, W. G. ;Willemze, R. ;Zwaan, F. E. ;Colly, L. P.
π
Article
π
1988
π
Springer-Verlag
β 455 KB
Seventy-two adults were treated for acute myelogenous leukaemia (AML). Forty-two had previously untreated AML and 30 had AML after a preleukaemic phase, refractory AML or relapsed AML. The previously untreated patients received a 7-day course of cytosine arabinoside (100 or 200 mg/m2 daily), daunoru